Heliyon (May 2024)

LINC02257 regulates colorectal cancer liver metastases through JNK pathway

  • Xiangan Wu,
  • Xiaokun Chen,
  • Xiao Liu,
  • Bao Jin,
  • Yuke Zhang,
  • Yuxin Wang,
  • Haifeng Xu,
  • Xueshuai Wan,
  • Yongchang Zheng,
  • Lai Xu,
  • Yi Xiao,
  • Zhengju Chen,
  • Haiwen Wang,
  • Yilei Mao,
  • Xin Lu,
  • Xinting Sang,
  • Lin Zhao,
  • Shunda Du

Journal volume & issue
Vol. 10, no. 10
p. e30841

Abstract

Read online

Background: Long noncoding RNAs (lncRNAs) have emerged as critical regulators of colorectal cancer (CRC) progression, but their roles and underlying mechanisms in colorectal cancer liver metastases (CRLMs) remain poorly understood. Methods: To explore the expression patterns and functions of lncRNAs in CRLMs, we analyzed the expression profiles of lncRNAs in CRC tissues using the TCGA database and examined the expression patterns of lncRNAs in matched normal, CRC, and CRLM tissues using clinical samples. We further investigated the biological roles of LINC02257 in CRLM using in vitro and in vivo assays, and verified its therapeutic potential in a mouse model of CRLM. Results: Our findings showed that LINC02257 was highly expressed in metastatic CRC tissues and its expression was negatively associated with overall survival. Functionally, LINC02257 promoted CRC cell growth, migration, metastasis, and inhibited cell apoptosis in vitro, and enhanced liver metastasis in vivo. Mechanistically, LINC02257 up-regulated phosphorylated c-Jun N-terminal kinase (JNK) to promote CRLM. Conclusions: Our study revealed that LINC02257 played a key role in the proliferation and metastasis of CRC cells through the LINC02257/JNK axis. Targeting this axis may represent a promising therapeutic strategy for the treatment of liver metastases in patients with CRC.

Keywords